Unjoni Ewropea - Malti - EMA (European Medicines Agency)

astrazeneca ab - moxetumomab pasudotox - leukemia, hairy taċ-ċelloli - aġenti antineoplastiċi - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - dexamethasone - macular edema; uveitis - ophthalmologicals, other ophthalmologicals - ozurdex huwa indikat għall-kura ta ' pazjenti adulti b'edema makulari tad-dijabete li ġejjin jew fergħa tar-retina-okklużjoni tal-vina (brvo) jew ċentrali tar-retina-okklużjoni tal-vina (crvo). ozurdex huwa indikat għall-kura ta 'pazjenti adulti b'infjammazzjoni ta' l-segment posterjuri ta ' l-għajn l-preżentazzjoni kif noninfectious uveite. ozurdex huwa indikat għall-kura ta 'pazjenti adulti b'indeboliment tal-vista minħabba ta' edima makulari dijabetika (dme) li huma pazjenti psewdoafakiċi jew li huma kkunsidrati bħala mhux biżżejjed li jirrispondu għal, jew li mhux tajbin għall-non-terapija tal-kortikosterojdi.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

samsung bioepis nl b.v. - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; myopia, degenerative - oftalmoloġiċi - byooviz is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloġiċi - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmoloġiċi - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

viatris limited - aflibercept - macular edema; retinal vein occlusion; diabetic retinopathy; myopia, degenerative; diabetes complications - oftalmoloġiċi - yesafili is indicated for adults for the treatment ofneovascular (wet) age-related macular degeneration (amd) (see section 5. 1),visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo) (see section 5. 1),visual impairment due to diabetic macular oedema (dme) (see section 5. 1),visual impairment due to myopic choroidal neovascularisation (myopic cnv) (see section 5.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

bayer ag - aflibercept - wet macular degeneration; macular edema; diabetes complications - oftalmoloġiċi - eylea huwa indikat għall-adulti għat-trattament ta': neovaskulari (imxarrba) relatata mal-età deġenerazzjoni makulari (amd);indeboliment tal-vista minħabba l-edima makulari sekondarja għal okklużjoni tal-vina tar-retina (il-fergħa rvo jew ċentrali rvo);indeboliment tal-vista minħabba ta 'edima makulari dijabetika (dme);indeboliment tal-vista minħabba myopic ġrieħi ta' neovaskularizzazzjoni korojdali (myopic cnv).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

novartis europharm limited - ranibizumab - wet macular degeneration; macular edema; diabetes complications; myopia, degenerative; choroidal neovascularization - oftalmoloġiċi - lucentis huwa indikat fl-adulti għall -: - trattament ta 'amd (umda) relatat mal-età deġenerazzjoni makulari (amd) - trattament ta' indeboliment tal-vista minħabba ġrieħi ta 'neovaskularizzazzjoni korojdali (cnv)il-kura ta' indeboliment tal-vista minħabba ta 'edima makulari dijabetika (dme)il-kura ta' indeboliment tal-vista minħabba l-edima makulari sekondarja għal okklużjoni tal-vina tar-retina (il-fergħa rvo jew ċentrali rvo).

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

upjohn eesv - pregabalin - epilepsy; anxiety disorders; neuralgia - anti-epilettiċi, , anti-epilettiċi oħrajn - newropatiku painlyrica huwa indikat għat-trattament tal-uġigħ nevrotiku periferali u ċentrali f'persuni adulti. epilepsylyrica huwa indikat bħala terapija aġġuntiva f'persuni adulti b'aċċessjonijiet parzjali bi jew mingħajr ġeneralizzazzjoni sekondarja. ta'ansjetà ġeneralizzata disorderlyrica huwa indikat għall-kura ta 'disturb ta' ansjetà ġeneralizzata (gad-generalised anxiety disorder) f'persuni adulti.

Unjoni Ewropea - Malti - EMA (European Medicines Agency)

upjohn eesv - pregabalin - anxiety disorders; epilepsy - anti-epilettiċi, - newropatiku painpregabalin pfizer huwa indikat għat-trattament tal-uġigħ nevrotiku periferali u ċentrali f'persuni adulti. epilepsypregabalin pfizer huwa indikat bħala terapija aġġuntiva f'persuni adulti b'aċċessjonijiet parzjali bi jew mingħajr ġeneralizzazzjoni sekondarja. ta'ansjetà ġeneralizzata disorderpregabalin pfizer huwa indikat għall-kura ta 'disturb ta' ansjetà Ġeneralizzata (gad-generalised anxiety disorder) f'persuni adulti.